Picture of Thx Pharma SA logo

ALTHX — Thx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Theranexus Cash Position Of 15.8 Million Euros At 30 Sept.

Nov 9 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * CASH POSITION AT SEPT 30 AT EUR 15.8 MILLION
    * THN101 WILL BE ENTERING PHASE II IN PATIENTS WITH
NEUROPATHIC
PAIN IN THE FIRST HALF OF 2019 - CEO
    * THN102, WHICH TARGETS TWO INDICATIONS, BEGAN ITS PHASE II
TRIAL
FOR PATIENTS SUFFERING FROM EXCESSIVE DAYTIME SLEEPINESS (EDS)
ASSOCIATED WITH PARKINSON'S DISEASE - CEO

Source text for Eikon:  ID:nACT55914 
Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Thx Pharma SA

See all news